Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
Allison Lambert, Jennifer O. Lam, Julie J. Paik, César Ugarte‐Gil, Michael Drummond, Trevor A. Crowell · 2015
Read Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis by Allison Lambert, Jennifer O. Lam, Julie J. Paik, César Ugarte‐Gil, Michael Drummond, Trevor A. Crowell (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w605005794.txt.
Description
Allison Lambert, Jennifer Lam, Julie Paik, and colleagues test whether acid-blocking drugs raise the risk of pneumonia. Their systematic review and meta-analysis appeared in PLOS ONE in 2015. Proton-pump inhibitors are among the most prescribed drugs worldwide. Some studies had tied them to community-acquired pneumonia.
The team reviewed thirty-three studies and pooled twenty-six. Together they covered more than six million people. Pooled results linked outpatient use of these drugs to higher pneumonia risk. The risk was greatest in the first month of therapy. It did not depend on dose or patient age. Because most evidence is observational, the link may not be causal. Still, the finding supports care when starting these drugs.
Catalog record
| CREATOR | Allison Lambert, Jennifer O. Lam, Julie J. Paik, César Ugarte‐Gil, Michael Drummond, Trevor A. Crowell |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / PLoS ONE |